James Cassella
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
James V.
Cassella is currently Chief Development Officer at Trevi Therapeutics, Inc. since 2024.
Formerly, Chief Development Officer at Sun Pharmaceutical Industries, Inc. from 2023 to 2024.
Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. from 2015 to 2023.
CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004.
Assistant Professor at Oberlin College.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of New Haven.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 06/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 30/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/09/2024 |
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2023 |
| ALEXZA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 29/01/2015 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Director Técnico/Científico/I+D | 01/06/2004 |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Haven
University of New Haven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.